Gupta et al identified potential HOTAIR/PRC2 binding sites by overexpressing HOTAIR in breast cancer cells and used antibodies to members of the PRC2 complex and H3K27me3 for ChIP-tiling array experiments [21]. Here, HOTAIR is linked to breast carcinoma.